|
Aug 29
|
FDA grants fast track designation to Life Molecular Imaging’s tau PET diagnostic
|
|
Aug 28
|
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions
|
|
Jul 25
|
AC Immune wins FDA fast track for Alzheimer’s vaccine
|
|
Jul 25
|
AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease
|
|
Jun 13
|
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
|
|
Jun 10
|
AC Immune SA (NASDAQ:ACIU): Are Analysts Optimistic?
|
|
May 13
|
Sector Update: Health Care Stocks Mixed Late Afternoon
|
|
May 13
|
Top Midday Gainers
|
|
May 13
|
Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
|
|
May 13
|
Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune
|
|
May 13
|
Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate
|
|
May 13
|
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
|
|
May 13
|
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
|
|
Apr 11
|
We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth
|
|
Mar 15
|
Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%
|
|
Mar 14
|
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
|
|
Jan 22
|
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
|
|
Dec 5
|
Is it a Good Idea to Invest in AC Immune (ACIU) Stock Now?
|
|
Dec 1
|
AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
|
|
Nov 27
|
Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year?
|